Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
25.21
-0.40 (-1.56%)
At close: Aug 31, 2026, 4:00 PM EDT
25.21
0.00 (0.00%)
Pre-market: Sep 1, 2026, 4:28 AM EDT
Ultragenyx Pharmaceutical Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 125 | 421 | 174 | 213.58 | 132.94 | 307.58 |
Short-Term Investments | 167 | 259 | 436 | 363.63 | 614.82 | 432.61 |
Cash & Short-Term Investments | 292 | 680 | 610 | 577.21 | 747.76 | 740.2 |
Cash Growth | -40.11% | 11.47% | 5.68% | -22.81% | 1.02% | -38.40% |
Accounts Receivable | 200 | 158 | 122 | 73.39 | 40.45 | 28.43 |
Other Receivables | 2 | 2 | 3 | 1.1 | 6.4 | 16 |
Receivables | 202 | 160 | 125 | 74.49 | 46.85 | 44.43 |
Inventory | 59 | 52 | 45 | 33.97 | 26.77 | 16.23 |
Prepaid Expenses | 44 | 46 | 30 | 44.51 | - | 55.75 |
Restricted Cash | 9 | 13 | 7 | 2.01 | 0.86 | - |
Other Current Assets | - | - | - | - | 61.66 | - |
Total Current Assets | 606 | 951 | 817 | 732.18 | 883.9 | 856.6 |
Property, Plant & Equipment | 235 | 267 | 292 | 314.47 | 285.73 | 176.18 |
Long-Term Investments | 144 | 57 | 135 | 199.9 | 148.97 | 293.86 |
Goodwill | 44 | 44 | 44 | 44.41 | 44.41 | 44.41 |
Other Intangible Assets | 172 | 176 | 178 | 166.27 | 160.11 | 130.79 |
Other Long-Term Assets | 63 | 37 | 37 | 33.79 | 22.34 | 20.56 |
Total Assets | 1,264 | 1,532 | 1,503 | 1,491 | 1,545 | 1,522 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 39 | 31 | 39 | 42.11 | 43.27 | 17.14 |
Accrued Expenses | 221 | 265 | 241 | 196.49 | 204.68 | 145.56 |
Current Portion of Long-Term Debt | 76 | 69 | 50 | 29.24 | - | - |
Current Portion of Leases | - | 12 | 10 | 12.6 | 11.78 | 11.07 |
Current Unearned Revenue | - | - | - | - | 1.48 | 7.61 |
Other Current Liabilities | 15 | 7 | 4 | - | - | - |
Total Current Liabilities | 351 | 384 | 344 | 280.44 | 261.21 | 181.37 |
Long-Term Debt | 1,126 | 1,147 | 820 | 862.33 | 875.44 | 351.79 |
Long-Term Leases | - | 24 | 30 | 30.57 | 19.81 | 30.9 |
Long-Term Unearned Revenue | - | - | - | - | - | 1.47 |
Long-Term Deferred Tax Liabilities | 30 | 30 | 30 | 30.06 | 31.67 | 33.31 |
Other Long-Term Liabilities | 41 | 20 | 17 | 12.21 | 4.82 | 1.01 |
Total Liabilities | 1,548 | 1,605 | 1,241 | 1,216 | 1,193 | 599.84 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | - | - | - | 0.08 | 0.07 | 0.07 |
Additional Paid-In Capital | 4,518 | 4,451 | 4,213 | 3,662 | 3,140 | 2,997 |
Retained Earnings | -4,809 | -4,532 | -3,957 | -3,388 | -2,781 | -2,074 |
Treasury Stock | -10 | -8 | -4 | -0.43 | - | - |
Comprehensive Income & Other | 10 | 9 | 3 | 1.08 | -6.57 | -1.4 |
Total Common Equity | -291 | -80 | 255 | 275.41 | 352.49 | 922.56 |
Minority Interest | 7 | 7 | 7 | - | - | - |
Shareholders' Equity | -284 | -73 | 262 | 275.41 | 352.49 | 922.56 |
Total Liabilities & Equity | 1,264 | 1,532 | 1,503 | 1,491 | 1,545 | 1,522 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 1,202 | 1,252 | 910 | 934.74 | 907.03 | 393.76 |
Net Cash (Debt) | -766 | -515 | -165 | -157.63 | -10.3 | 605.37 |
Net Cash Growth | - | - | - | - | - | -26.90% |
Net Cash Per Share | -7.62 | -5.22 | -1.82 | -2.14 | -0.15 | 8.93 |
Filing Date Shares Outstanding | 98.29 | 96.43 | 92.5 | 82.34 | 70.22 | 69.38 |
Total Common Shares Outstanding | 98.3 | 96.4 | 92.48 | 82.32 | 70.2 | 69.34 |
Working Capital | 255 | 567 | 473 | 451.75 | 622.69 | 675.24 |
Book Value Per Share | -2.96 | -0.83 | 2.76 | 3.35 | 5.02 | 13.30 |
Tangible Book Value | -507 | -300 | 33 | 64.74 | 147.98 | 747.37 |
Tangible Book Value Per Share | -5.16 | -3.11 | 0.36 | 0.79 | 2.11 | 10.78 |
Land | - | 17 | 17 | 16.62 | 16.62 | 15.49 |
Buildings | - | 182 | 182 | 181.36 | 2.8 | - |
Machinery | - | 125 | 119 | 116.26 | 70.28 | 54.31 |
Construction In Progress | - | - | - | - | 189.45 | 76.85 |
Leasehold Improvements | - | 55 | 58 | 58.68 | 43.94 | 44.08 |